 EMERYVILLE, Calif., Feb. 28, 2022 GLOBE NEWSWIRE -- Lucira Health, Inc. Lucira Health or Lucira Nasdaq: LHDX, a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will report fourth quarter 2021 financial results on, Thursday, March 10, 2022. Luciras management will host a conference call and webcast at 1:30 p.m. PT 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. 